18F-FLT PET

You have access
¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma
Joseph G. Crompton, Wesley R. Armstrong, Mark A. Eckardt, Ameen Seyedroudbari, William D. Tap, Sarah M. Dry, Evan R. Abt, Jeremie Calais, Ken Herrmann, Johannes Czernin, Fritz C. Eilber and Matthias R. Benz

Journal of Nuclear Medicine May 1, 2022, 63 (5) 708-712; DOI: https://doi.org/10.2967/jnumed.121.262502
Open Access
Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using ¹⁸F-Fluorothymidine PET
Rohini Sharma, Marianna Inglese, Suraiya Dubash, Haonan Lu, David J. Pinato, Chandan Sanghera, Neva Patel, Anthony Chung, Paul D. Tait, Francesco Mauri, William R. Crum, Tara D. Barwick and Eric O. Aboagye

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1743-1748; DOI: https://doi.org/10.2967/jnumed.119.240598
You have access
Thymidine Metabolism as a Confounding Factor for 3′-Deoxy-3′-¹⁸F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model
Sonja Schelhaas, Lydia Wachsmuth, Sven Hermann, Natascha Rieder, Astrid Heller, Kathrin Heinzmann, Davina J. Honess, Donna-Michelle Smith, Inga B. Fricke, Nathalie Just, Sabrina Doblas, Ralph Sinkus, Christian Döring, Klaus P. Schäfers, John R. Griffiths, Cornelius Faber, Richard Schneider, Eric O. Aboagye and Andreas H. Jacobs

Journal of Nuclear Medicine July 1, 2018, 59 (7) 1063-1069; DOI: https://doi.org/10.2967/jnumed.117.206250
You have access
Prognostic Value of ¹⁸F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with ¹⁸F-FDG PET and Ki-67 in 100 Patients
Camilla B. Johnbeck, Ulrich Knigge, Seppo W. Langer, Annika Loft, Anne Kiil Berthelsen, Birgitte Federspiel, Tina Binderup and Andreas Kjaer

Journal of Nuclear Medicine December 1, 2016, 57 (12) 1851-1857; DOI: https://doi.org/10.2967/jnumed.116.174714
You have access
Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation
Suzanne C. van Es, Clasina M. Venema, Andor W.J.M. Glaudemans, Marjolijn N. Lub-de Hooge, Sjoerd G. Elias, Ronald Boellaard, Geke A.P. Hospers, Carolina P. Schröder and Elisabeth G.E. de Vries

Journal of Nuclear Medicine February 1, 2016, 57 (Supplement 1) 96S-104S; DOI: https://doi.org/10.2967/jnumed.115.157974
You have access
A Phase II Study of 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688
Lale Kostakoglu, Fenghai Duan, Michael O. Idowu, Paul R. Jolles, Harry D. Bear, Mark Muzi, Jean Cormack, John P. Muzi, Daniel A. Pryma, Jennifer M. Specht, Linda Hovanessian-Larsen, John Miliziano, Sharon Mallett, Anthony F. Shields and David A. Mankoff; on behalf of the ACRIN 668 Investigative Team

Journal of Nuclear Medicine November 1, 2015, 56 (11) 1681-1689; DOI: https://doi.org/10.2967/jnumed.115.160663
You have access
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3′-Deoxy-3′-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging
Sonja Schelhaas, Lydia Wachsmuth, Thomas Viel, Davina J. Honess, Kathrin Heinzmann, Donna-Michelle Smith, Sven Hermann, Stefan Wagner, Michael T. Kuhlmann, Carsten Müller-Tidow, Klaus Kopka, Otmar Schober, Michael Schäfers, Richard Schneider, Eric O. Aboagye, John Griffiths, Cornelius Faber and Andreas H. Jacobs

Journal of Nuclear Medicine June 1, 2014, 55 (6) 983-988; DOI: https://doi.org/10.2967/jnumed.113.133348
You have access
3′-Deoxy-3′-¹⁸F-Fluorothymidine PET Predicts Response to ^V600EBRAF-Targeted Therapy in Preclinical Models of Colorectal Cancer
Eliot T. McKinley, R. Adam Smith, Ping Zhao, Allie Fu, Samir A. Saleh, Md. Imam Uddin, M. Kay Washington, Robert J. Coffey and H. Charles Manning

Journal of Nuclear Medicine March 1, 2013, 54 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.112.108456

Main menu

User menu

Search

18F-FLT PET